JP2025084837A5 - - Google Patents
Info
- Publication number
- JP2025084837A5 JP2025084837A5 JP2025028722A JP2025028722A JP2025084837A5 JP 2025084837 A5 JP2025084837 A5 JP 2025084837A5 JP 2025028722 A JP2025028722 A JP 2025028722A JP 2025028722 A JP2025028722 A JP 2025028722A JP 2025084837 A5 JP2025084837 A5 JP 2025084837A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263314257P | 2022-02-25 | 2022-02-25 | |
| US63/314,257 | 2022-02-25 | ||
| PCT/US2023/013710 WO2023164057A1 (en) | 2022-02-25 | 2023-02-23 | Di-cyclopropyl based il-17a modulators and uses thereof |
| JP2024550207A JP7642932B1 (ja) | 2022-02-25 | 2023-02-23 | ジ－シクロプロピル系ｉｌ－１７ａモジュレータ及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024550207A Division JP7642932B1 (ja) | 2022-02-25 | 2023-02-23 | ジ－シクロプロピル系ｉｌ－１７ａモジュレータ及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025084837A JP2025084837A (ja) | 2025-06-03 |
| JP2025084837A5 true JP2025084837A5 (https=) | 2026-03-03 |
Family
ID=85776163
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024550207A Active JP7642932B1 (ja) | 2022-02-25 | 2023-02-23 | ジ－シクロプロピル系ｉｌ－１７ａモジュレータ及びその使用 |
| JP2025028722A Pending JP2025084837A (ja) | 2022-02-25 | 2025-02-26 | ジ－シクロプロピル系ｉｌ－１７ａモジュレータ及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024550207A Active JP7642932B1 (ja) | 2022-02-25 | 2023-02-23 | ジ－シクロプロピル系ｉｌ－１７ａモジュレータ及びその使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20250177383A1 (https=) |
| EP (1) | EP4482823A1 (https=) |
| JP (2) | JP7642932B1 (https=) |
| KR (1) | KR20240157703A (https=) |
| CN (1) | CN119072465A (https=) |
| AR (1) | AR128586A1 (https=) |
| AU (1) | AU2023223283A1 (https=) |
| CA (1) | CA3244866A1 (https=) |
| CL (1) | CL2024002479A1 (https=) |
| CO (1) | CO2024011455A2 (https=) |
| DO (1) | DOP2024000163A (https=) |
| IL (1) | IL314827A (https=) |
| JO (1) | JOP20240187A1 (https=) |
| MX (1) | MX2024010218A (https=) |
| PE (1) | PE20251689A1 (https=) |
| TW (1) | TW202345807A (https=) |
| WO (1) | WO2023164057A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024208228A1 (en) * | 2023-04-03 | 2024-10-10 | Nuphase Therapeutics (Hangzhou) Limited., Co. | Novel compounds, compositions comprising the same and uses thereof |
| WO2025201533A1 (en) * | 2024-03-28 | 2025-10-02 | Nuphase Therapeutics (Shanghai) Limited., Co. | Novel acidic compounds, compositions comprising the same and uses thereof |
| WO2025201532A1 (en) * | 2024-03-28 | 2025-10-02 | Nuphase Therapeutics (Shanghai) Limited., Co. | Novel pegylation compounds, compositions comprising the same and uses thereof |
| WO2025209395A1 (en) * | 2024-04-03 | 2025-10-09 | Innocare Pharma Inc. | Il-17 modulators and used thereof |
| WO2026021539A1 (zh) * | 2024-07-24 | 2026-01-29 | 深圳信立泰药业股份有限公司 | 双环il-17a/f抑制剂及其制备方法与应用 |
| WO2026020343A1 (zh) * | 2024-07-24 | 2026-01-29 | 祐森健恒生物医药科技（中山）有限公司 | Il-17a调节剂化合物及其用途 |
| WO2026040422A1 (en) * | 2024-08-19 | 2026-02-26 | Shenzhen Ionova Life Science Co., Ltd. | Novel interleukin-17 inhibtors |
| CN119192167B (zh) * | 2024-11-28 | 2025-03-21 | 英矽智能科技(上海)有限公司 | 一类抑制il-17的化合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1087725C (zh) | 1994-03-25 | 2002-07-17 | 同位素技术有限公司 | 用氘代方法增强药物效果 |
| US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| BR112021010453A2 (pt) * | 2018-12-19 | 2021-08-24 | Leo Pharma A/S | Composto, e, composição farmacêutica |
| TWI839461B (zh) * | 2019-02-06 | 2024-04-21 | 美商戴斯阿爾法股份有限公司 | Il-17a調節物及其用途 |
| IL291345B2 (en) * | 2019-09-16 | 2024-04-01 | Dice Alpha Inc | Il-17a modulators and uses thereof |
| MX2022015554A (es) * | 2020-06-12 | 2023-01-30 | Leo Pharma As | Moduladores de molecula peque?a de interleucina 17 (il-17). |
| MX2024000504A (es) * | 2021-07-09 | 2024-04-05 | Dice Alpha Inc | Moduladores de il-17a basados en fenilacetamida y usos de los mismos. |
-
2023
- 2023-02-23 US US18/841,320 patent/US20250177383A1/en active Pending
- 2023-02-23 WO PCT/US2023/013710 patent/WO2023164057A1/en not_active Ceased
- 2023-02-23 CA CA3244866A patent/CA3244866A1/en active Pending
- 2023-02-23 AR ARP230100420A patent/AR128586A1/es unknown
- 2023-02-23 MX MX2024010218A patent/MX2024010218A/es unknown
- 2023-02-23 CN CN202380035861.0A patent/CN119072465A/zh active Pending
- 2023-02-23 AU AU2023223283A patent/AU2023223283A1/en active Pending
- 2023-02-23 EP EP23713773.2A patent/EP4482823A1/en active Pending
- 2023-02-23 TW TW112106593A patent/TW202345807A/zh unknown
- 2023-02-23 KR KR1020247031990A patent/KR20240157703A/ko active Pending
- 2023-02-23 JP JP2024550207A patent/JP7642932B1/ja active Active
- 2023-02-23 PE PE2024001841A patent/PE20251689A1/es unknown
- 2023-02-23 IL IL314827A patent/IL314827A/en unknown
-
2024
- 2024-08-19 JO JOJO/P/2024/0187A patent/JOP20240187A1/ar unknown
- 2024-08-19 CL CL2024002479A patent/CL2024002479A1/es unknown
- 2024-08-21 DO DO2024000163A patent/DOP2024000163A/es unknown
- 2024-08-23 CO CONC2024/0011455A patent/CO2024011455A2/es unknown
-
2025
- 2025-02-26 JP JP2025028722A patent/JP2025084837A/ja active Pending